Effect of two different standards of analgosedation for diagnostic and interventional heart catheterization in pediatric patients

Not Applicable

• Conditions: Q23; Q24; Q25; Q26; Effects and side effects of analgosedation; Q20; Q21; Q22; Congenital malformations of cardiac chambers and connections; Congenital malformations of cardiac septa

• Registration Number: DRKS00005262
• Lead Sponsor: Klinik für Pädiatrische KardiologieUniversitätsklinikum des Saarlandes

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2012-03-31
• Study Start: 2015-07-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

Patients aged between one month and 18 years with the need for a diagnostic and/or interventional cardiac catheterization.

Exclusion Criteria

Missing consent of the parents or the legal representatives; infectious disease at the moment of cardiac catheterization or to one week prior to examination; history of known allergic or incompatible reactions to the planned medication; anomalies of the airways or acute or chronic diseases of the respiratory tract which may lead to intubation or other complications of the airways during the sedation; pregnancy.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility of cardiac catheterization; discontinuation of cardiac catheterization or necessity for a switch of the method of analgosedation

Secondary Outcome Measures

Name	Time	Method
Difference in laboratory parameters (e. g. pC02, lactate), quality of sedation (documentation of unrest, complications, necessary interventions and additional application of sedatives), incidence of complications during and after sedation